Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Kidney Neoplasms × Immunotherapy × Clear all

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 16 Esophageal Neoplasms 7 Melanoma 6 Lung Neoplasms 6 Colorectal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Esophageal Squamous Cell Carcinoma 4 Small Cell Lung Carcinoma 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Carcinoma, Transitional Cell 2 Unresectable Biliary Tract Cancer 1 Triple Negative Breast Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Small Cell Lung Cancer Extensive Stage 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Neuroblastoma 1 Nasopharyngeal Neoplasms 1 Muscle-Invasive Bladder Carcinoma 1 Motor Activity 1

Interventions

cabozantinib 7 pembrolizumab 6 Nivolumab 6 Ipilimumab 4 Axitinib 4 Radiosurgery 3 Blood Specimen Collection 3 zimberelimab 2 lenvatinib 2 Ultrasonography 2 Surveys and Questionnaires 2 Radiotherapy 2 Biopsy 2 tislelizumab 1 polyethylene glycol 3350 1 pazopanib 1 palbociclib 1 olaparib 1 gallium Ga 68 dotatate 1 cyclopropapyrroloindole 1 brodalumab 1 belzutifan 1 atezolizumab 1 anlotinib 1 adagrasib 1 Watchful Waiting 1 Vincristine 1 Therapeutics 1 Temozolomide 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06583070 2026-01-28

COSTAR

Peking University First Hospital

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡